ARTICLE | Company News
CytRx, SynthRx deal
October 27, 2003 8:00 AM UTC
SynthRx received an exclusive license to commercialize CYTR's co-polymer products, including Flocor and Opti-Vax. CYTR will receive a 19.9% stake in SynthRx and an upfront payment, and is eligible for milestones and royalties. ...